Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
ADIA Nutrition Inc. (OTC Pink: ADIA) has announced the acquisition of Biolete , a company specializing in protein coffee with mushrooms. This strategic move expands ADIA's portfolio in the functional beverage market. The acquisition includes Biolete's trademarks, inventory, customer base, and website. ADIA acquired 100% of Biolete through an equity offer of preferred shares regulated under Rule 144, which doesn't affect current outstanding shares.
Biolete's products combine collagen protein and mushrooms in coffee, offering energy-boosting benefits without negative side effects. The acquisition is expected to immediately contribute to ADIA's earnings and provide new growth opportunities. ADIA plans to integrate Biolete's operations and expand distribution channels to accelerate product adoption.
ADIA Nutrition Inc. (OTC Pink: ADIA) ha annunciato l'acquisizione di Biolete, un'azienda specializzata nel caffè proteico con funghi. Questa mossa strategica amplia il portafoglio di ADIA nel mercato delle bevande funzionali. L'acquisizione comprende i marchi registrati di Biolete, l'inventario, la clientela e il sito web. ADIA ha acquisito il 100% di Biolete tramite un'offerta di azioni privilegiate regolate dalla Regola 144, che non influisce sulle azioni attualmente in circolazione.
I prodotti di Biolete combinano proteine collageniche e funghi nel caffè, offrendo benefici energetici senza effetti collaterali negativi. Si prevede che l'acquisizione contribuirà immediatamente agli utili di ADIA e offrirà nuove opportunità di crescita. ADIA intende integrare le operazioni di Biolete e ampliare i canali di distribuzione per accelerare l'adozione del prodotto.
ADIA Nutrition Inc. (OTC Pink: ADIA) ha anunciado la adquisición de Biolete, una empresa especializada en café proteico con hongos. Este movimiento estratégico amplía el portafolio de ADIA en el mercado de bebidas funcionales. La adquisición incluye las marcas registradas de Biolete, el inventario, la base de clientes y el sitio web. ADIA adquirió el 100% de Biolete mediante una oferta de acciones preferentes reguladas bajo la Regla 144, que no afecta a las acciones actualmente en circulación.
Los productos de Biolete combinan proteína de colágeno y hongos en café, ofreciendo beneficios energéticos sin efectos secundarios negativos. Se espera que la adquisición contribuya de inmediato a las ganancias de ADIA y proporcione nuevas oportunidades de crecimiento. ADIA planea integrar las operaciones de Biolete y expandir los canales de distribución para acelerar la adopción del producto.
ADIA Nutrition Inc. (OTC Pink: ADIA)는 버섯이 들어간 단백질 커피를 전문으로 하는 Biolete를 인수했다고 발표했습니다. 이 전략적 결정은 ADIA의 기능성 음료 시장 포트폴리오를 확장합니다. 인수에는 Biolete의 상표, 재고, 고객 기반 및 웹사이트가 포함됩니다. ADIA는 현재 발행된 주식에 영향을 미치지 않는 제144조에 따라 규제되는 우선주 제안을 통해 Biolete의 100%를 인수했습니다.
Biolete의 제품은 커피에 콜라겐 단백질과 버섯을 결합하여 부작용 없이 에너지 증진 효과를 제공합니다. 이 인수는 ADIA의 수익에 즉각적인 기여를 할 것으로 예상되며 새로운 성장 기회를 제공할 것입니다. ADIA는 Biolete의 운영을 통합하고 제품 채택을 가속화하기 위해 유통 경로를 확장할 계획입니다.
ADIA Nutrition Inc. (OTC Pink: ADIA) a annoncé l'acquisition de Biolete, une entreprise spécialisée dans le café protéiné aux champignons. Ce mouvement stratégique élargit le portefeuille d'ADIA sur le marché des boissons fonctionnelles. L'acquisition comprend les marques de Biolete, l'inventaire, la clientèle et le site Web. ADIA a acquis 100 % de Biolete par le biais d'une offre d'actions privilégiées régulées par la règle 144, sans impact sur les actions actuellement en circulation.
Les produits de Biolete combinent protéines de collagène et champignons dans le café, offrant des bienfaits énergétiques sans effets indésirables. On s'attend à ce que l'acquisition contribue immédiatement aux bénéfices d'ADIA et offre de nouvelles opportunités de croissance. ADIA prévoit d'intégrer les opérations de Biolete et d'étendre ses canaux de distribution pour accélérer l'adoption des produits.
ADIA Nutrition Inc. (OTC Pink: ADIA) hat die Übernahme von Biolete angekündigt, einem Unternehmen, das sich auf Protein-Kaffee mit Pilzen spezialisiert hat. Dieser strategische Schritt erweitert ADIAs Portfolio im Markt für funktionale Getränke. Die Übernahme umfasst die Markenzeichen von Biolete, den Lagerbestand, die Kundenbasis und die Website. ADIA hat 100 % von Biolete durch ein Angebot für bevorrechtigte Aktien erworben, das unter Regel 144 geregelt ist und keine Auswirkungen auf die derzeit ausgegebenen Aktien hat.
Die Produkte von Biolete kombinieren Kollagenprotein und Pilze im Kaffee und bieten energiesteigernde Vorteile ohne negative Nebenwirkungen. Es wird erwartet, dass die Übernahme sofort zu ADIAs Einnahmen beiträgt und neue Wachstumschancen bietet. ADIA plant, die Operationen von Biolete zu integrieren und die Vertriebskanäle zu erweitern, um die Produktakzeptanz zu beschleunigen.
- Acquisition of Biolete expands ADIA's product portfolio in the growing functional beverage market
- Acquisition includes valuable assets: trademarks, inventory, customer base, and website
- Deal structure (preferred shares) doesn't dilute current shareholders
- Immediate expected contribution to ADIA's earnings
- Potential for accelerated growth through expanded distribution channels
- None.
Winter Park, Florida--(Newsfile Corp. - July 23, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce the acquisition of Biolete LLC, a pioneering company in the development of protein coffee with mushrooms. This strategic move marks a significant milestone for ADIA Nutrition as it continues to expand its portfolio and provide original solutions to meet the evolving needs of its customers.
Biolete
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/217169_bioleteimage1.jpg
Protein coffees and mushroom extracts have recently gained considerable attention for their potential health benefits, including increased energy, improved focus, and enhanced immune support. Biolete prides itself for its US manufactured coffee with organic ingredients of collagen protein and mushrooms which gives the energy-boosting benefits of coffee without the negative side effects. By acquiring
"We are thrilled to welcome Biolete to the ADIA family," said Larry Powalisz, CEO of ADIA Nutrition Inc. "Biolete's innovative approach to combining the benefits of protein and mushrooms in a delicious coffee beverage aligns perfectly with our mission to revolutionize the supplement industry and empower individuals to prioritize their health and well-being. We are excited to leverage our combined resources and expertise to bring Biolete's exceptional product to a wider audience."
Biolete accepted ADIA's equity offer of preferred shares that are regulated under Rule 144 (which does not affect the current outstanding shares of the company). This acquisition is a testament to ADIA's commitment to expanding its product offerings and delivering value to their shareholders.
Kevin Masson, founder of Biolete, expressed his enthusiasm for the acquisition, stating, "I am excited to have sold Biolete to ADIA Nutrition as an equity investment. I believe that ADIA Nutrition is the perfect partner to help take Biolete to the next level and continue to provide our customers with the highest quality products."
The acquisition of Biolete is expected to immediately attribute to ADIA Nutrition's earnings and will provide new opportunities for growth and expansion. The company plans to integrate Biolete's operations seamlessly and add additional distribution channels to accelerate the adoption of its protein and mushroom coffee.
For media inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
adianutrition.com or X (Twitter) "adia_nutrition"
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/217169
FAQ
What company did ADIA Nutrition Inc. (ADIA) acquire?
How did ADIA Nutrition (ADIA) finance the acquisition of Biolete?
What assets are included in ADIA's acquisition of Biolete?
How is the Biolete acquisition expected to impact ADIA Nutrition's (ADIA) earnings?
